eMedicine Specialties > Ophthalmology > Cornea

Keratitis, Interstitial

Author: Parag A Majmudar, MD, Fellowship Co-Director, Department of Ophthalmology, Cornea and Refractive Surgery Service, Assistant Professor, Rush-Presbyterian-St Luke's Medical Center
Contributor Information and Disclosures

Updated: Dec 14, 2007

Introduction

Background

Interstitial keratitis (IK) is a broad, descriptive term that has become synonymous with syphilitic disease. Although syphilis remains the leading cause of IK, various bacterial, viral, parasitic, and autoimmune causes of IK exist.

Pathophysiology

By definition, IK is a nonsuppurative inflammation, which is characterized by cellular infiltration of the corneal stroma. In general, no primary involvement of the corneal epithelium or endothelium occurs. Inflammation may be either the direct result of an infectious process or, more commonly, secondary to an immunologic response to a specific foreign antigen. This immunological response may take the form of antigen-antibody complex deposition, complement-mediated disease, or a delayed-type hypersensitivity reaction.

Frequency

United States

IK generally is seen in the context of syphilis and, less commonly, in the context of herpes and Cogan syndrome.

International

In various countries in which mycobacterial diseases (eg, tuberculosis, leprosy) are endemic, these and other parasitic causes of IK may be seen with greater frequency.

Mortality/Morbidity

Ocular morbidity generally is in the form of corneal scarring, which can interfere with visual acuity.

Race

No known racial predilection exists.

Sex

No gender predilection exists.

Age

IK generally is a disease that manifests in the third to fifth decades of life.

Clinical

History

  • In the acute phase, IK typically causes decreased vision, photophobia, tearing, pain, and blepharospasm. Late phase symptoms consist of decreased visual acuity but little ocular discomfort.
  • Congenital syphilis tends to cause acute symptoms in childhood. Patients may give a history of one or both eyes being red and painful for months as a child. They may remember being admitted to the hospital or confined to bed, and they may not have been allowed to go to school for many months. They may give a history of prolonged intravenous antibiotics or multiple shots as treatment.

Physical

  • Clinically, IK is characterized by areas of dense, white, stromal necrosis and vascularization in the acute phase, which may be either diffuse or focal and typically results in scarring and thinning in the later phases of inflammation.
  • The active vascularization contributes to the pinkish color of the cornea and is termed the salmon patch of Hutchinson. These vessels often regress, leaving behind remnants known as ghost vessels.
  • Once the initial inflammation has resolved, which may take many months, the cornea may exhibit mild-to-severe scarring and thinning. The scarring tends to be in the mid to posterior corneal stroma.

Causes

IK may be attributed to a number of systemic illnesses, including bacterial, viral, and parasitic infections, as well as Cogan syndrome, which can be associated with various systemic vasculitides.

  • Bacterial infections
    • Syphilis: IK in syphilis may be due to an immune-mediated reaction to an unknown treponemal antigen. IK may be seen in congenital and acquired syphilis.
    • Congenital syphilis
      • IK due to congenital syphilis is commonly a late finding. Most cases of IK develop in patients aged 5-20 years. Acute IK may be triggered by ocular surface inflammation and following intraocular surgery. Corneal inflammation most often affects the deep stromal layers either as multifocal infiltrates or as a diffuse process. Corneal stromal edema may result from the inflammation, resulting in the ground glass cornea. Variable corneal stromal neovascularization depending on the severity of the inflammation may be present. Typically, the neovascularization begins at the corneal limbus and may occur in the level, although it most commonly is seen in the deeper stromal layers. Stromal inflammation overlying the vessel often causes the salmon-colored patch due to the pinkish color imparted by the stromal vessels. Intrastromal hemorrhage also may occur.
      • IK may progress to the regression phase, during which scarring of the corneal stromal and collagen remodeling occur. The superficial vessels resorb, and the deeper vessels may constrict, resulting in the ghost vessels that are seen as a late finding of syphilitic IK.
      • Congenital syphilitic IK is typically bilateral in 80% of cases. However, the two eyes are very rarely involved simultaneously; usually, the contralateral eye is affected after an interval of time, which may be as short as 2 months or as long as 15 years, following inflammation of the first eye.
    • Acquired syphilis
      • Corneal disease in acquired syphilis is rare, although IK may be seen. Typically, IK is unilateral in the context of acquired syphilis. IK may occur relatively soon following the primary general infection, but it more often occurs many years later with the onset of pain, photophobia, tearing, and blurred vision, similar to the symptoms seen in acute IK in congenital syphilis. In general, the symptoms are less severe and of shorter duration.
      • Clinical findings of IK in acquired syphilis very closely resemble those seen in IK in congenital syphilis. Late findings of IK in acquired syphilis include opacification of the stroma with ghost vessels and thinning. Endothelial changes in the form of redundant basement membrane at the level of the Descemet membrane also may be present. Endothelial decompensation may follow, resulting in central corneal edema later in life.
    • Mycobacterial infections: Tuberculosis and leprosy are two mycobacterial infections that may be causative agents in the pathogenesis of IK.
      • Internationally, tuberculosis remains an important public health issue, and, in the United States, tuberculosis has become a relevant topic due to increased immigration from endemic areas, as well as due to the human immunodeficiency virus (HIV). Although primary tuberculosis infection of the eye is extremely rare, IK may be associated with pulmonary tuberculosis. Even in this setting, it is extremely rare and, when present, usually is unilateral. In keeping with the other types of IK, the pathogenesis seems to be an immune reaction to tuberculous antigens within the cornea. Clinical findings are similar to IK due to other disorders.
      • Leprosy is caused by Mycobacterium leprae and characteristically infects the skin and peripheral nerves. Two forms of leprosy exist, tuberculous and lepromatous. IK also may be an ocular finding of leprosy (Hansen disease), and, in contrast to that seen in tuberculosis, lepromatous IK usually is bilateral. Another distinguishing characteristic of lepromatous IK is that the organisms have been found throughout the stroma, implying that a direct infectious etiology may occur, in contrast to an immunologic etiology. Clinical findings of IK are similar to that in tuberculous IK; however, prognosis may be poor due to the widespread involvement of the corneal nerves in lepromatous IK.
    • Lyme disease: The causative organism in Lyme disease is the spirochete Borrelia burgdorferi and typically is transmitted by the deer tick vector, Ixodes.
      • Lyme disease clinically is distinguished by 3 stages, and ocular involvement typically occurs in stage 2 and stage 3. Stage 1 represents the viral prodrome with a flulike illness and the typical bull's eye lesions on the skin, erythema chronicum migrans. Stage 2 is characterized by neuro-ophthalmologic manifestations.
      • Keratitis along with uveitis and vasculitis may occur in stage 3. Keratitis is a rare feature of Lyme disease, but, when present, it carries a typical finding of IK with the exception of stromal edema, which is not a common factor in Lyme IK. Lyme keratitis also can appear as large nummular infiltrates in various levels of the stroma without corneal neovascularization.
  • Parasitic infections: Parasitic infections are rare causes of IK commonly seen in the United States.
    • Acanthamoeba is a free-living amoeba, which may cause a severe keratitis, especially in patients with a history of contact lens wear and more typically contact lens abuse. In prior decades, the use of homemade saline solutions was found to be a cause of Acanthamoeba keratitis. The use of contact lenses while swimming, typically in a fresh water environment, also is another risk factor. Acanthamoeba keratitis may have a variety of presenting characteristics, but the most significant symptom is pain out of proportion to clinical findings. Although epitheliopathy may exist, primary stromal involvement, including inflammation edema, may be seen, which resembles IK. In typical Acanthamoeba keratitis, stromal neovascularization is not an early finding.
    • Onchocerciasis (river blindness) is the result of infection by the nematode Onchocerca volvulus. Ocular involvement is the result of the migration of the microfilariae to the ocular tissues. IK caused by onchocerciasis has been described as beginning in the peripheral cornea, followed by progressive spread centripetally. Vascularization and complete opacification of the cornea may result, but corneal thinning is not a significant feature in this condition.
    • Leishmania is a protozoan agent commonly seen in Asia, Africa, and South America. It is carried by the sand fly vector and is divided into cutaneous and visceral forms. Typically, 2 types of keratitis are seen. Necrotizing keratitis may progress to corneal necrosis and perforation. However, a second presentation is that of typical IK with late corneal scarring and thinning.
    • Trypanosoma cruzi is responsible for the American form or Chagas disease, and Trypanosoma brucei is responsible for the African form, also known as African sleeping sickness. IK may be seen in the African form with the typical features described previously.
    • Microsporidia are small intracellular protozoans, which have been isolated from patients with acquired immunodeficiency syndrome (AIDS) who had developed superficial keratoconjunctivitis. They are rare causes of keratitis in immunocompetent individuals.
  • Viral infections
    • Herpetic infections of the cornea comprise a myriad of clinical findings. A complete discussion is beyond the scope of this section. Herpetic stromal disease may take the form of IK and represents an important entity in the differential diagnosis. Typical findings of IK may be present along with an immune ring, which may be diagnostic.
    • Epstein-Barr virus also belongs to the herpes family of viruses and may have variable presentation in corneal disease. Unilateral or bilateral, multifocal or discrete infiltrates may be present, which may benefit from topical corticosteroids.
    • Mumps typically causes lacrimal gland inflammation, but cornea involvement may occur with a variable presentation, ranging from punctate epithelial keratopathy to nummular keratitis.
    • Cornea involvement in measles typically is a superficial keratitis and generally is self-limiting. However, measles has been associated with vitamin A deficiency in malnutrition, and the combination of these factors may promote stromal infiltration and perforation.
  • Cogan syndrome
    • The triad of nonsyphilitic IK, vestibuloauditory disease, and associated autoimmune vasculitis is known as Cogan syndrome and was first described in 1945. In this condition, a sudden onset of vestibuloauditory symptoms (eg, tinnitus, vertigo, nausea, vomiting) occurs, along with corneal inflammation and often an association with autoimmune disorders (eg, polyarteritis nodosa, Wegener granulomatosis, rheumatoid arthritis). In contrast to the deafness associated with syphilitic IK, the hearing loss in Cogan syndrome also has the vestibular symptoms described earlier. Although the exact pathogenesis is unknown, the disease process probably represents an immune reaction against the common antigen found in the cornea and in the inner ear.
    • Corneal findings are very similar to those seen in syphilitic IK, with lymphocytic infiltration of the deep stroma with variable neovascularization.

More on Keratitis, Interstitial

Overview: Keratitis, Interstitial
Differential Diagnoses & Workup: Keratitis, Interstitial
Treatment & Medication: Keratitis, Interstitial
Follow-up: Keratitis, Interstitial
References

References

  1. Cali A, Meisler DM, Lowder CY, Lembach R, Ayers L, Takvorian PM, et al. Corneal microsporidioses: characterization and identification. J Protozool. Nov-Dec 1991;38(6):215S-217S. [Medline].

  2. Cogan DG, Dickersin GR. Nonsyphilitic interstitial keratitis with vestibuloauditory symptoms. A case with fatal aortitis. Arch Ophthalmol. Feb 1964;71:172-5. [Medline].

  3. Cogan DS. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol. 1945;33:144-9.

  4. Dekkers NW, Treskes M. Measles keratitis. Ophthalmol Clin North Am. 1994;74:574.

  5. Dinis da Gama R, Cidade M. Images in clinical medicine. Interstitial keratitis as the initial expression of syphilitic reactivation. N Engl J Med. Jun 6 2002;346(23):1799. [Medline].

  6. Ffytche T. Ocular leprosy--the continuing challenge. Int Ophthalmol. Sep 1991;15(5):289-93. [Medline].

  7. Goegebuer A, Ajay L, Claerhout I, Kestelyn P. Results of penetrating keratoplasty in syphilitic interstitial keratitis. Bull Soc Belge Ophtalmol. 2003;(290):35-9. [Medline].

  8. Helm CJ, Holland GN. Ocular tuberculosis. Surv Ophthalmol. Nov-Dec 1993;38(3):229-56. [Medline].

  9. Jones BR, McGill JI, Steele AD. Recurrent suppurative kerato-uveitis with loss of eye due to infection by Acanthamoeba castellani. Trans Ophthalmol Soc U K. Jul 1975;95(2):210-3. [Medline].

  10. Labetoulle M, Offret H, Bournerias I, Frau E. Rapid improvement of chronic interstitial keratitis with acitretin. Br J Ophthalmol. Dec 2002;86(12):1445-6. [Medline].

  11. Lee ME, Lindquist TD. Syphilitic interstitial keratitis. JAMA. Nov 24 1989;262(20):2921. [Medline].

  12. Matoba AY. Ocular disease associated with Epstein-Barr virus infection. Surv Ophthalmol. Sep-Oct 1990;35(2):145-50. [Medline].

  13. North DP. The treatment of interstitial keratitis. Br Med J. Jul 3 1954;4878:7-9. [Medline].

  14. Norton EW, Cogan DG. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms; a long-term follow-up. AMA Arch Ophthalmol. May 1959;61(5):695-7. [Medline].

  15. Orsoni JG, Zavota L, Manzotti F, Gonzales S. Syphilitic interstitial keratitis: treatment with immunosuppressive drug combination therapy. Cornea. Jul 2004;23(5):530-2. [Medline].

  16. Pepose JS. Herpes simplex keratitis: role of viral infection versus immune response. Surv Ophthalmol. Mar-Apr 1991;35(5):345-52. [Medline].

  17. Rabb MF, Fine M. Penetrating keratoplasty in interstitial keratitis. Am J Ophthalmol. Jun 1969;67(6):907-17. [Medline].

  18. Roizenblatt J. Interstitial keratitis caused by American (mucocutaneous) leishmaniasis. Am J Ophthalmol. Feb 1979;87(2):175-9. [Medline].

  19. Tamesis RR, Foster CS. Ocular syphilis. Ophthalmology. Oct 1990;97(10):1281-7. [Medline].

  20. Taylor HR, Semba RD, Newland HS, Keyvan-Larijani E, White A, Dukuly Z, et al. Ivermectin treatment of patients with severe ocular onchocerciasis. Am J Trop Med Hyg. May 1989;40(5):494-500. [Medline].

  21. Zaidman GW. The ocular manifestations of Lyme disease. Int Ophthalmol Clin. 1993;33(1):9-22. [Medline].

Further Reading

Keywords

interstitial keratitis, IK, syphilitic keratitis, Cogan syndrome, syphilitic disease, syphilis, herpes

Contributor Information and Disclosures

Author

Parag A Majmudar, MD, Fellowship Co-Director, Department of Ophthalmology, Cornea and Refractive Surgery Service, Assistant Professor, Rush-Presbyterian-St Luke's Medical Center
Parag A Majmudar, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, International Society of Refractive Surgery, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Medical Editor

Fernando H Murillo-Lopez, MD, Senior Surgeon, Unidad Privada de Oftalmologia CEMES
Fernando H Murillo-Lopez, MD is a member of the following medical societies: American Academy of Ophthalmology
Disclosure: Nothing to disclose.

Pharmacy Editor

Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles
Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Managing Editor

Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Jefferson Medical College; Co-Chairman of the Cornea Service, Co-Chairman of Refractive Surgery Department, Wills Eye Hospital
Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, Eye Bank Association of America, Pennsylvania Medical Society, and Philadelphia County Medical Society
Disclosure: Nothing to disclose.

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.